[Recommendations for normalizing the medical practices of burn treatment during the outbreak of coronavirus disease 2019]

Zhonghua Shao Shang Za Zhi. 2020 Jun 20;36(6):465-469. doi: 10.3760/cma.j.cn501120-20200224-00083.
[Article in Chinese]

Abstract

2019 novel coronavirus (2019-nCoV) is one of the beta coronaviruses and is identified as the pathogen of the severe " coronavirus disease 2019 (COVID-19)" in 2019. China manages COVID-19 according to the reguirement of the highest level infectious diseases in China. Currently, the prevention and control of COVID-19 in China is at a critical period. Burn Department as an emergency discipline is confronted with risk of 2019-nCoV infection. Based on the guidelines for the diagnosis and treatment of COVID-19 (6th trial edition), in combination with the latest literature at home and abroad, the features of the COVID-19, the recommendations for the COVID-19 prevention and control issued by the National Health Commission of China, and the management experience of COVID-19 diagnosis and treatment of other related disciplines, we put forward some recommendations for the medical practices of burn treatment during the outbreak of the COVID-19 in outpatient and emergency, inpatient treatment, and the management of operation theatres and wards, etc. We hope these recommendations could benefit the medical professionals in the field of burn treatment and relevant hospital management during the outbreak of COVID-19, improve burn treatment, and avoid or reduce the risk of infection of medical staff.

新型冠状病毒属于β属的冠状病毒,是导致2019年严重疫情——新型冠状病毒肺炎暴发的元凶。我国按照中国最高级别的传染病来管理新型冠状病毒肺炎。目前仍是新型冠状病毒肺炎疫情防控的关键时期,作为急诊科室的烧伤科面临着严峻的风险。为提高患者救治率,避免或减少医务人员感染,笔者依据国家最新发布的《新型冠状病毒肺炎诊疗方案(试行第六版)》,结合国内外最新的文献资料,根据新型冠状病毒肺炎基本特性和国家卫生健康委员会关于新型冠状病毒肺炎的防治建议,并参考兄弟学科的诊疗管理经验,在门急诊、住院治疗、手术及病区管理等方面提出指导新型冠状病毒肺炎疫情期间烧伤科诊疗工作的建议,希望对烧伤救治同道们和相关医院管理者有所裨益。.

Keywords: Burns; Coronavirus disease 2019; Epidemic prevention and control; Recommendations for diagnosis and treatment.

MeSH terms

  • Betacoronavirus
  • Burns / therapy*
  • COVID-19
  • China
  • Coronavirus Infections*
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2